646 RESECTION OF HEPATOCELLULAR CANCER (HCC) WITH MACROSCOPIC VASCULAR INVASION (MVI)

S. Roayaie; Ghalib Jibara; Josep M. Llovet; D.M. Labow; M.E. Schwartz

doi:10.1016/s0168-8278(11)60648-x

Related publications

Article2001

p27Kip1 Is an independent predictor of recurrence after surgical resection of hepatocellular carcinoma (HCC)

Carolina Armengol, Loreto Boix, Oriol Bachs, M Solé, Josep M. Llovet, J Rodés, Jordi Bruix

Journal of Hepatology

Article2025

THU-078 Artificial intelligence-driven prediction of biology-related poor outcome and presence of vascular invasion in hepatocellular carcinoma

Agavni Mesropian, Tobias Paul Seraphin, Laura Žigutyteè, James Brooks, Ezequiel Mauro, Albert Gris‐Oliver, Roser Pinyol, Carla Montironi, Marko van Treeck, Jakob Nikolas Kather, Tom Luedde, Josep M. Llovet

Journal of Hepatology

Article2001

Chemoembolization improves survival in patients with unresectable hepatocellular carcinoma (HCC)

Josep M. Llovet, María Isabel Real, R. Vilana, Ramón Planas, S. Coll, John J. Aponte, Carmen Ayuso, María Sala, Jordi Muchart, R. Costa, J Rodés, Jordi Bruix

Journal of Hepatology

Article2001

VEGF and iNOS expression in human hepatocellular carcinoma (HCC)

Loreto Boix, Carolina Armengol, M Solé, Wladimiro Jiménez, Josep M. Llovet, J Rodés, Jordi Bruix

Journal of Hepatology

Article2009

67 EFFICACY AND SAFETY OF SORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): SUBANALYSIS OF SHARP TRIAL BASED ON BARCELONA CLINIC LIVER CANCER (BCLC) STAGE

Jordi Bruix, Jean‐Luc Raoul, Morris Sherman, Ming Shan, Giuseppe Lentini, Andrea Nadel, D. Voliotis, Josep M. Llovet

Journal of Hepatology

646 RESECTION OF HEPATOCELLULAR CANCER (HCC) WITH MACROSCOPIC VASCULAR INVASION (MVI)

Abstract

Discussion(0)

Related publications

p27Kip1 Is an independent predictor of recurrence after surgical resection of hepatocellular carcinoma (HCC)

THU-078 Artificial intelligence-driven prediction of biology-related poor outcome and presence of vascular invasion in hepatocellular carcinoma

Chemoembolization improves survival in patients with unresectable hepatocellular carcinoma (HCC)

VEGF and iNOS expression in human hepatocellular carcinoma (HCC)

67 EFFICACY AND SAFETY OF SORAFENIB IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC): SUBANALYSIS OF SHARP TRIAL BASED ON BARCELONA CLINIC LIVER CANCER (BCLC) STAGE